PCM
VIVS

Prelude Capital Management’s VivoSim Labs VIVS Stock Holding History

Prelude Capital Management’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-22
Closed -$43K – 2180
2014
Q2 		$43K Buy
+22
New +$36.9K 0.01% 1426

Other funds holding VIVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Prelude Capital Management's VIVS Position: Q4 2017 in Review

Prelude Capital Management sold out of VivoSim Labs (VIVS) in Q4 2017, closing a stake of 222 shares — an estimated $118K sold.

Prelude Capital Management first reported a position in VIVS in Q3 2016 and held it in 4 quarters. The position peaked at $124K in Q1 2017. 123 funds tracked by Wall St. Rank hold VIVS as of Q4 2017.

  • Prelude Capital Management reported no remaining VivoSim Labs position as of Q4 2017 after selling out during the quarter.
  • Prelude Capital Management sold 222 VivoSim Labs shares in Q4 2017, an estimated $118K.
  • Prelude Capital Management first reported a position in VivoSim Labs in Q3 2016 and held it in 4 quarters.
  • Prelude Capital Management's VivoSim Labs position peaked at $124K in Q1 2017.
  • 123 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2017.

Based on Prelude Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.